STOCK TITAN

CERYVYN THERAPEUTICS LTD (CKDXF) Net Income by Year

CKDXF

CERYVYN THERAPEUTICS LTD reported a net loss of $162.8M in fiscal year 2025. This represents an increase of 26.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters CERYVYN THERAPEUTICS LTD has filed alongside them.

FY2025 annual
Net Income -$162.8M
YoY +26.1%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CKDXF Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$162.8M+26.1%-$220.2M-54.5%-$142.5M-53.5%-$92.8M-104.7%-$45.3M-307.7%-$11.1M+25.6%-$15.0M

CKDXF Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ2'2210-QQ4'2110-KQ4'2010-KQ1'2010-K
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More CERYVYN THERAPEUTICS LTD financials

Frequently Asked Questions

What was CERYVYN THERAPEUTICS LTD's net income in fiscal year 2025?

CERYVYN THERAPEUTICS LTD reported a net loss of $162.8M in fiscal year 2025.

How fast is CERYVYN THERAPEUTICS LTD's net income growing?

CERYVYN THERAPEUTICS LTD (CKDXF) net income rose by 26.1% year over year, from -$220.2M to -$162.8M in fiscal year 2025.

How has CERYVYN THERAPEUTICS LTD's net income changed over the years?

Across the 7 fiscal years this page covers, CERYVYN THERAPEUTICS LTD (CKDXF) net income went from -$15.0M in fiscal year 2019 to -$162.8M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what CERYVYN THERAPEUTICS LTD (CKDXF) reported on that line in every period on record.